Target Name: INE1
NCBI ID: G8552
Review Report on INE1 Target / Biomarker Content of Review Report on INE1 Target / Biomarker
INE1
Other Name(s): inactivation escape 1 | NCRNA00010 | Inactivation escape 1

INE1: A Protein Implicated in Cell Survival and Migration

INE1, or Inactivation Escape 1, is a protein that is expressed in various tissues throughout the body. It is a key regulator of cell survival and has been implicated in a number of diseases, including cancer. In recent years, researchers have been interested in studying INE1 as a potential drug target or biomarker, due to its unique biology and its potential to influence a wide range of cellular processes.

The INE1 protein is composed of 254 amino acid residues and has a calculated molecular weight of 31.1 kDa. It is expressed in a variety of tissues, including the brain, heart, liver, and muscle. INE1 is involved in a number of cellular processes, including cell adhesion, migration, and survival. It is also involved in the regulation of cellular signaling pathways, including the TGF-β pathway.

One of the key functions of INE1 is its role in cell adhesion. This is an important process that allows cells to stick together and form tissues. INE1 is involved in the formation of tight junctions, which are specialized barriers that allow cells to communicate with one another and to form tissues. It is also involved in the regulation of cell-cell adhesion, which is critical for the development and maintenance of tissues.

INE1 is also involved in the regulation of cell migration. This is an important process that allows cells to move to new locations in the body and to form new tissues. INE1 is involved in the regulation of cell-cell adhesion, which is critical for the migration of cells. It is also involved in the regulation of the actin cytoskeleton, which is important for cell movement.

Another function of INE1 is its role in cell survival. This is an important process that allows cells to continue to function and to survive in the face of various stressors, including those that are caused by diseases. INE1 is involved in the regulation of cell stress responses, which are critical for the survival of cells.

INE1 is also involved in the regulation of cellular signaling pathways. This is an important process that allows cells to communicate with one another and to respond to various signaling molecules. INE1 is involved in the regulation of the TGF-β pathway, which is a key signaling pathway that is involved in the development and maintenance of tissues.

As a potential drug target, INE1 has been studied extensively in recent years. Researchers have identified a number of potential drug compounds that can inhibit the activity of INE1, including small molecules, peptides, and proteins. These compounds have been tested in a variety of cellular models and have been shown to be effective in inhibiting the activity of INE1.

One of the challenges in studying INE1 as a potential drug target is its complex biology. INE1 is involved in a wide range of cellular processes and has a complex mechanism of regulation. This makes it difficult to predict the exact effects of potential drugs and to develop effective treatments. However, researchers are continuing to study INE1 and to identify new potential drug compounds that can inhibit its activity.

In addition to its potential as a drug target, INE1 has also been identified as a potential biomarker. This is a molecule that can be used as a diagnostic marker or as a target for diagnostic tests. INE1 has been shown to be expressed in a variety of cancer types and has been identified as a potential biomarker for cancer. This makes it an attractive target for researchers who are interested in developing new diagnostic tests or therapies for cancer.

Overall, INE1 is a protein that is involved in a wide range of cellular processes and has been implicated in a number of diseases. As a potential drug target and biomarker, INE1 is an attractive target for researchers who are interested in understanding its biology and developing new treatments. Further research is needed to fully understand its role in

Protein Name: Inactivation Escape 1

The "INE1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about INE1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

INE2 | INF2 | ING1 | ING2 | ING2-DT | ING3 | ING4 | ING5 | INGX | INHA | INHBA | INHBA-AS1 | INHBB | INHBC | INHBE | INHCAP | Inhibitor of Apoptosis Proteins (IAPs) | Inhibitory kappaB Kinase (IKK) | INIP | INKA1 | INKA2 | INKA2-AS1 | INMT | INMT-MINDY4 | Innate Repair Receptor (IRR) | INO80 | INO80 complex | INO80B | INO80B-WBP1 | INO80C | INO80D | INO80E | Inositol 1,4,5-Trisphosphate Receptor (InsP3R) | Inositol hexakisphosphate kinase | Inositol Monophosphatase | INPP1 | INPP4A | INPP4B | INPP5A | INPP5B | INPP5D | INPP5E | INPP5F | INPP5J | INPP5K | INPPL1 | INS | INS-IGF2 | INSC | INSIG1 | INSIG2 | INSL3 | INSL4 | INSL5 | INSL6 | INSM1 | INSM2 | INSR | INSRR | Insulin-like growth factor | Insulin-like growth factor 2 mRNA binding protein | Insulin-like growth factor 2 mRNA-binding protein 1 (isoform 2) | Insulin-like growth factor-binding protein | INSYN1 | INSYN2A | INSYN2B | Integrator complex | Integrin alpha1beta1 (VLA-1) receptor | Integrin alpha2beta1 (VLA-2) receptor | Integrin alpha2beta3 Receptor | Integrin alpha3beta1 receptor | Integrin alpha4beta1 (VLA-4) receptor | Integrin alpha4beta7 (LPAM-1) receptor | Integrin alpha5beta1 (VLA-5) receptor | Integrin alpha5beta3 receptor | Integrin alpha6beta1 Receptor | Integrin alpha6beta4 receptor | Integrin alpha7beta1 Receptor | Integrin alpha9beta1 receptor | Integrin alphaEbeta7 receptor | Integrin alphaLbeta2 (LFA-1) receptor | Integrin alphaMbeta2 (MAC-1) Receptor | Integrin alphavbeta1 | Integrin alphavbeta3 (vitronectin) receptor | Integrin alphavbeta5 receptor | Integrin alphavbeta6 receptor | Integrin alphavbeta8 Receptor | Integrin Receptor | Integrin-linked kinase | Interferon | Interferon-alpha (IFN-alpha) | Interferon-gamma Receptor | Interleukin 17 | Interleukin 21 receptor complex | Interleukin 23 complex (IL-23) | Interleukin 35 | Interleukin-1 | Interleukin-1 receptor-associated kinase (IRAK) | Interleukin-12 (IL-12) | Interleukin-18 Receptor Complex